These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 25358874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Horino T, Ito H, Tanimoto N, Yoshida T, Sasaoka A, Chijiwa T, Hosokawa T, Hashimoto K.
    Nihon Jinzo Gakkai Shi; 2003 Jul 18; 45(2):104-8. PubMed ID: 12703406
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jul 18; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 15. Effects of ramipril and valsartan on proteinuria and renal function in patients with nondiabetic proteinuria.
    Bilić M, Munjas-Samarin R, Ljubanović D, Horvatić I, Galesić K.
    Coll Antropol; 2011 Dec 18; 35(4):1061-6. PubMed ID: 22397239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Dec 18; 873():79-86. PubMed ID: 26269025
    [Abstract] [Full Text] [Related]

  • 18. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
    Lou T, Wang C, Chen Z, Shi C, Tang H, Liu X, Yin P, Yu X.
    Nephrology (Carlton); 2006 Apr 18; 11(2):113-6. PubMed ID: 16669971
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Apr 18; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.